COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities
Pages 45-46
Ananda M. Chakrabarty

DOI: http://dx.doi.org/10.6000/1929-2279.2016.05.02.1

Published: 15 April 2016

COMMENTARY

Download Full Article